ReviewJournal of clinical medicine2018
A Practical Review of the Emerging Direct Anticoagulants, Laboratory Monitoring, and Reversal Agents.
Review in Journal of clinical medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- The effect of anticoagulation therapy on the surgical outcomes of minimally invasive major gastrointestinal surgery.Surgical endoscopy · 2025Article
- Efficacy and safety of direct oral anticoagulants versus warfarin in the treatment of cerebral venous sinus thrombosis.Acta neurologica Belgica · 2024Article
- A functional RNA-origami as direct thrombin inhibitor with fast-acting and specific single-molecule reversal agents in vivo model.Molecular therapy : the journal of the American Society of Gene Therapy · 2024Article
- Portal vein thrombosis: A concise review (Review).Experimental and therapeutic medicine · 2021Review
- Intravenous Immunoglobulin (IVIG) in Severe Heparin-Induced Thrombocytopenia (HIT) in a Traumatic Brain Injury (TBI) Patient with Cerebral Venous Sinus Thrombosis (CVST).Neurocritical care · 2021Article
- Direct Oral Anticoagulants: From Randomized Clinical Trials to Real-World Clinical Practice.Frontiers in pharmacology · 2021Review
- Direct oral anticoagulants (DOACs) and neck of femur fractures: Standardising the perioperative management and time to surgery.Journal of clinical orthopaedics and trauma · 2021Article
- Retrospective Review on the Safety and Efficacy of Direct Oral Anticoagulants Compared With Warfarin in Patients With Cirrhosis.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2020Article
- Chronic Kidney Disease and Its Impact on a Prothrombotic State in Patients with Atrial Fibrillation.Journal of clinical medicine · 2020Article
- Therapeutic strategies for thrombosis: new targets and approaches.Nature reviews. Drug discovery · 2020Review
- Emergency Visits for Oral Anticoagulant Bleeding.Journal of general internal medicine · 2020Article
- Oral Anticoagulant Therapy-When Art Meets Science.Journal of clinical medicine · 2019Review
- Assessment of ICD-10-CM code assignment validity for case finding of outpatient anticoagulant-related bleeding among Medicare beneficiaries.Pharmacoepidemiology and drug safety · 2019Article
- Update on Management of Portal Vein Thrombosis and the Role of Novel Anticoagulants.Journal of clinical and translational hepatology · 2019Review
- Rapidly Neutralizable and Highly Anticoagulant Thrombin-Binding DNA Aptamer Discovered by MACE SELEX.Molecular therapy. Nucleic acids · 2019Article
- The acceptability of a direct oral anticoagulant monitoring regimen among patients with atrial fibrillation: a pilot study.International journal of clinical pharmacy · 2019Article
- Anticoagulation Across Care Transitions: Identifying Minimum Data to Maximize Drug Safety.Joint Commission journal on quality and patient safety · 2018Article
- Dabigatran: Clinical correlation of drug and its dose with risk of stroke and bleeding.Perspectives in clinical researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Millions of patients in the United States use anticoagulation for a variety of indications, such as the prevention of stroke in those with atrial fibrillation (AF) and the treatment and prevention of venous thrombosis. For over six decades warfarin was the only available oral anticoagulant, but now several DOACs are available and their use has become more prevalent in recent years. In spite of this increased use, many physicians remain reluctant to prescribe DOACs due to concerns about bleeding and reversibility.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.